Our Team.

With over 20 years of drug development experience in the industry and as a prominent thought leader at DARPA, we are well-positioned to not only comprehend the challenges of drug development in pediatric brain tumors but also to empathize with the personal journey. Our connection to this cause is deeply personal, as we have experienced it firsthand through Max, our son, brother, and friend.